Global and China Histone Deacetylase (HDAC) Inhibitors Market Insights, Forecast to 2026

Global and China Histone Deacetylase (HDAC) Inhibitors Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Histone Deacetylase(HDAC) Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Histone Deacetylase(HDAC) Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Histone Deacetylase(HDAC) Inhibitors Market Size Growth Rate by Type
1.4.2 Hydroxamic Acids
1.4.3 Cyclic Tetrapeptides
1.4.4 Benzamides
1.4.5 Electrophilic Ketones
1.4.6 Aliphatic Acid
1.5 Market by Application
1.5.1 Global Histone Deacetylase(HDAC) Inhibitors Market Size Growth Rate by Application
1.5.2 Psychiatry and Neurology
1.5.3 Cancer Treatment
1.5.4 HIV
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Histone Deacetylase(HDAC) Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Histone Deacetylase(HDAC) Inhibitors Revenue 2015-2026
2.1.2 Global Histone Deacetylase(HDAC) Inhibitors Sales 2015-2026
2.2 Global Histone Deacetylase(HDAC) Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Histone Deacetylase(HDAC) Inhibitors Historical Market Size by Region (2015-2020)
2.3.1 Global Histone Deacetylase(HDAC) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Histone Deacetylase(HDAC) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Histone Deacetylase(HDAC) Inhibitors Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Histone Deacetylase(HDAC) Inhibitors Sales Forecast by Region (2021-2026)
2.4.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue Forecast by Region (2021-2026)
3 Global Histone Deacetylase(HDAC) Inhibitors Competitor Landscape by Players
3.1 Global Top Histone Deacetylase(HDAC) Inhibitors Sales by Manufacturers
3.1.1 Global Histone Deacetylase(HDAC) Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Global Histone Deacetylase(HDAC) Inhibitors Manufacturers by Revenue
3.2.1 Global Histone Deacetylase(HDAC) Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Histone Deacetylase(HDAC) Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Histone Deacetylase(HDAC) Inhibitors Revenue in 2019
3.2.5 Global Histone Deacetylase(HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Histone Deacetylase(HDAC) Inhibitors Price by Manufacturers
3.4 Global Histone Deacetylase(HDAC) Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Histone Deacetylase(HDAC) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Histone Deacetylase(HDAC) Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Histone Deacetylase(HDAC) Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Histone Deacetylase(HDAC) Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Histone Deacetylase(HDAC) Inhibitors Sales by Type (2015-2020)
4.1.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue by Type (2015-2020)
4.1.3 Histone Deacetylase(HDAC) Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Histone Deacetylase(HDAC) Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Histone Deacetylase(HDAC) Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Histone Deacetylase(HDAC) Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Histone Deacetylase(HDAC) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Histone Deacetylase(HDAC) Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Histone Deacetylase(HDAC) Inhibitors Sales by Application (2015-2020)
5.1.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue by Application (2015-2020)
5.1.3 Histone Deacetylase(HDAC) Inhibitors Price by Application (2015-2020)
5.2 Histone Deacetylase(HDAC) Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Histone Deacetylase(HDAC) Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Histone Deacetylase(HDAC) Inhibitors Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Histone Deacetylase(HDAC) Inhibitors Market Size YoY Growth 2015-2026
6.1.1 China Histone Deacetylase(HDAC) Inhibitors Sales YoY Growth 2015-2026
6.1.2 China Histone Deacetylase(HDAC) Inhibitors Revenue YoY Growth 2015-2026
6.1.3 China Histone Deacetylase(HDAC) Inhibitors Market Share in Global Market 2015-2026
6.2 China Histone Deacetylase(HDAC) Inhibitors Market Size by Players (International and Local Players)
6.2.1 China Top Histone Deacetylase(HDAC) Inhibitors Players by Sales (2015-2020)
6.2.2 China Top Histone Deacetylase(HDAC) Inhibitors Players by Revenue (2015-2020)
6.3 China Histone Deacetylase(HDAC) Inhibitors Historic Market Review by Type (2015-2020)
6.3.1 China Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Type (2015-2020)
6.3.2 China Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Type (2015-2020)
6.3.3 China Histone Deacetylase(HDAC) Inhibitors Price by Type (2015-2020)
6.4 China Histone Deacetylase(HDAC) Inhibitors Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Histone Deacetylase(HDAC) Inhibitors Sales Forecast by Type (2021-2026)
6.4.2 China Histone Deacetylase(HDAC) Inhibitors Revenue Forecast by Type (2021-2026)
6.4.3 China Histone Deacetylase(HDAC) Inhibitors Price Forecast by Type (2021-2026)
6.5 China Histone Deacetylase(HDAC) Inhibitors Historic Market Review by Application (2015-2020)
6.5.1 China Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Application (2015-2020)
6.5.2 China Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Application (2015-2020)
6.5.3 China Histone Deacetylase(HDAC) Inhibitors Price by Application (2015-2020)
6.6 China Histone Deacetylase(HDAC) Inhibitors Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Histone Deacetylase(HDAC) Inhibitors Sales Forecast by Application (2021-2026)
6.6.2 China Histone Deacetylase(HDAC) Inhibitors Revenue Forecast by Application (2021-2026)
6.6.3 China Histone Deacetylase(HDAC) Inhibitors Price Forecast by Application (2021-2026)
7 North America
7.1 North America Histone Deacetylase(HDAC) Inhibitors Market Size YoY Growth 2015-2026
7.2 North America Histone Deacetylase(HDAC) Inhibitors Market Facts & Figures by Country
7.2.1 North America Histone Deacetylase(HDAC) Inhibitors Sales by Country (2015-2020)
7.2.2 North America Histone Deacetylase(HDAC) Inhibitors Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Histone Deacetylase(HDAC) Inhibitors Market Size YoY Growth 2015-2026
8.2 Europe Histone Deacetylase(HDAC) Inhibitors Market Facts & Figures by Country
8.2.1 Europe Histone Deacetylase(HDAC) Inhibitors Sales by Country
8.2.2 Europe Histone Deacetylase(HDAC) Inhibitors Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Histone Deacetylase(HDAC) Inhibitors Market Size YoY Growth 2015-2026
9.2 Asia Pacific Histone Deacetylase(HDAC) Inhibitors Market Facts & Figures by Country
9.2.1 Asia Pacific Histone Deacetylase(HDAC) Inhibitors Sales by Region (2015-2020)
9.2.2 Asia Pacific Histone Deacetylase(HDAC) Inhibitors Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Histone Deacetylase(HDAC) Inhibitors Market Size YoY Growth 2015-2026
10.2 Latin America Histone Deacetylase(HDAC) Inhibitors Market Facts & Figures by Country
10.2.1 Latin America Histone Deacetylase(HDAC) Inhibitors Sales by Country
10.2.2 Latin America Histone Deacetylase(HDAC) Inhibitors Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Market Facts & Figures by Country
11.2.1 Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Sales by Country
11.2.2 Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Gloucester Pharmaceuticals
12.1.1 Gloucester Pharmaceuticals Corporation Information
12.1.2 Gloucester Pharmaceuticals Description and Business Overview
12.1.3 Gloucester Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Products Offered
12.1.5 Gloucester Pharmaceuticals Recent Development
12.2 Spectrum Pharmaceuticals
12.2.1 Spectrum Pharmaceuticals Corporation Information
12.2.2 Spectrum Pharmaceuticals Description and Business Overview
12.2.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Products Offered
12.2.5 Spectrum Pharmaceuticals Recent Development
12.3 Pharmacyclics
12.3.1 Pharmacyclics Corporation Information
12.3.2 Pharmacyclics Description and Business Overview
12.3.3 Pharmacyclics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Products Offered
12.3.5 Pharmacyclics Recent Development
12.4 Roche(Ventana Medical Systems)
12.4.1 Roche(Ventana Medical Systems) Corporation Information
12.4.2 Roche(Ventana Medical Systems) Description and Business Overview
12.4.3 Roche(Ventana Medical Systems) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Roche(Ventana Medical Systems) Histone Deacetylase(HDAC) Inhibitors Products Offered
12.4.5 Roche(Ventana Medical Systems) Recent Development
12.5 Signal Rx
12.5.1 Signal Rx Corporation Information
12.5.2 Signal Rx Description and Business Overview
12.5.3 Signal Rx Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Signal Rx Histone Deacetylase(HDAC) Inhibitors Products Offered
12.5.5 Signal Rx Recent Development
12.6 SpeBio
12.6.1 SpeBio Corporation Information
12.6.2 SpeBio Description and Business Overview
12.6.3 SpeBio Sales, Revenue and Gross Margin (2015-2020)
12.6.4 SpeBio Histone Deacetylase(HDAC) Inhibitors Products Offered
12.6.5 SpeBio Recent Development
12.7 Quimatryx
12.7.1 Quimatryx Corporation Information
12.7.2 Quimatryx Description and Business Overview
12.7.3 Quimatryx Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Quimatryx Histone Deacetylase(HDAC) Inhibitors Products Offered
12.7.5 Quimatryx Recent Development
12.8 TetraLogic Pharmaceuticals
12.8.1 TetraLogic Pharmaceuticals Corporation Information
12.8.2 TetraLogic Pharmaceuticals Description and Business Overview
12.8.3 TetraLogic Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Products Offered
12.8.5 TetraLogic Pharmaceuticals Recent Development
12.9 Onyx
12.9.1 Onyx Corporation Information
12.9.2 Onyx Description and Business Overview
12.9.3 Onyx Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Onyx Histone Deacetylase(HDAC) Inhibitors Products Offered
12.9.5 Onyx Recent Development
12.10 Mirati Therapeutics
12.10.1 Mirati Therapeutics Corporation Information
12.10.2 Mirati Therapeutics Description and Business Overview
12.10.3 Mirati Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Products Offered
12.10.5 Mirati Therapeutics Recent Development
12.11 Gloucester Pharmaceuticals
12.11.1 Gloucester Pharmaceuticals Corporation Information
12.11.2 Gloucester Pharmaceuticals Description and Business Overview
12.11.3 Gloucester Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Products Offered
12.11.5 Gloucester Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Histone Deacetylase(HDAC) Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Histone Deacetylase(HDAC) Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Histone Deacetylase(HDAC) Inhibitors Market Segments
Table 2. Ranking of Global Top Histone Deacetylase(HDAC) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Histone Deacetylase(HDAC) Inhibitors Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Hydroxamic Acids
Table 5. Major Manufacturers of Cyclic Tetrapeptides
Table 6. Major Manufacturers of Benzamides
Table 7. Major Manufacturers of Electrophilic Ketones
Table 8. Major Manufacturers of Aliphatic Acid
Table 9. Global Histone Deacetylase(HDAC) Inhibitors Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Histone Deacetylase(HDAC) Inhibitors Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Histone Deacetylase(HDAC) Inhibitors Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Regions (2015-2020)
Table 13. Global Histone Deacetylase(HDAC) Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Histone Deacetylase(HDAC) Inhibitors Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Histone Deacetylase(HDAC) Inhibitors Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Histone Deacetylase(HDAC) Inhibitors Sales Share by Manufacturers (2015-2020)
Table 17. Global Histone Deacetylase(HDAC) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Histone Deacetylase(HDAC) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase(HDAC) Inhibitors as of 2019)
Table 19. Histone Deacetylase(HDAC) Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Histone Deacetylase(HDAC) Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Histone Deacetylase(HDAC) Inhibitors Price (2015-2020) (USD/Pcs)
Table 22. Histone Deacetylase(HDAC) Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Histone Deacetylase(HDAC) Inhibitors Product Type
Table 24. Date of International Manufacturers Enter into Histone Deacetylase(HDAC) Inhibitors Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Histone Deacetylase(HDAC) Inhibitors Sales by Type (2015-2020) (K Pcs)
Table 27. Global Histone Deacetylase(HDAC) Inhibitors Sales Share by Type (2015-2020)
Table 28. Global Histone Deacetylase(HDAC) Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Histone Deacetylase(HDAC) Inhibitors Revenue Share by Type (2015-2020)
Table 30. Histone Deacetylase(HDAC) Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Histone Deacetylase(HDAC) Inhibitors Sales Share by Type (2021-2026)
Table 32. Global Histone Deacetylase(HDAC) Inhibitors Sales by Application (2015-2020) (K Pcs)
Table 33. Global Histone Deacetylase(HDAC) Inhibitors Sales Share by Application (2015-2020)
Table 34. Global Histone Deacetylase(HDAC) Inhibitors Sales Share by Application (2021-2026)
Table 35. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Histone Deacetylase(HDAC) Inhibitors Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share Forecast by Application (2021-2026)
Table 38. China Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs) of Key Companies (2015-2020)
Table 39. China Histone Deacetylase(HDAC) Inhibitors Sales Share by Company (2015-2020)
Table 40. China Histone Deacetylase(HDAC) Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 41. China Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs) by Type (2015-2020)
Table 42. China Histone Deacetylase(HDAC) Inhibitors Sales Share by Type (2015-2020)
Table 43. China Histone Deacetylase(HDAC) Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. China Histone Deacetylase(HDAC) Inhibitors Price (K Pcs) by Type (2015-2020)
Table 45. China Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs) by Type (2021-2026)
Table 46. China Histone Deacetylase(HDAC) Inhibitors Sales Share by Type (2021-2026)
Table 47. China Histone Deacetylase(HDAC) Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. China Histone Deacetylase(HDAC) Inhibitors Revenue Share by Type (2021-2026)
Table 49. China Histone Deacetylase(HDAC) Inhibitors Price (K Pcs) by Type (2021-2026)
Table 50. China Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs) by Application (2015-2020)
Table 51. China Histone Deacetylase(HDAC) Inhibitors Sales Share by Application (2015-2020)
Table 52. China Histone Deacetylase(HDAC) Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. China Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs) by Application (2021-2026)
Table 54. China Histone Deacetylase(HDAC) Inhibitors Sales Share by Application (2021-2026)
Table 55. China Histone Deacetylase(HDAC) Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. China Histone Deacetylase(HDAC) Inhibitors Revenue Share by Application (2021-2026)
Table 57. North America Histone Deacetylase(HDAC) Inhibitors Sales by Country (2015-2020) (K Pcs)
Table 58. North America Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Country (2015-2020)
Table 59. North America Histone Deacetylase(HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Country (2015-2020)
Table 61. Europe Histone Deacetylase(HDAC) Inhibitors Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Country (2015-2020)
Table 63. Europe Histone Deacetylase(HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Region (2015-2020)
Table 69. Latin America Histone Deacetylase(HDAC) Inhibitors Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Histone Deacetylase(HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Country (2015-2020)
Table 77. Gloucester Pharmaceuticals Corporation Information
Table 78. Gloucester Pharmaceuticals Description and Business Overview
Table 79. Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Product
Table 81. Gloucester Pharmaceuticals Recent Development
Table 82. Spectrum Pharmaceuticals Corporation Information
Table 83. Spectrum Pharmaceuticals Description and Business Overview
Table 84. Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Spectrum Pharmaceuticals Product
Table 86. Spectrum Pharmaceuticals Recent Development
Table 87. Pharmacyclics Corporation Information
Table 88. Pharmacyclics Description and Business Overview
Table 89. Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Pharmacyclics Product
Table 91. Pharmacyclics Recent Development
Table 92. Roche(Ventana Medical Systems) Corporation Information
Table 93. Roche(Ventana Medical Systems) Description and Business Overview
Table 94. Roche(Ventana Medical Systems) Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Roche(Ventana Medical Systems) Product
Table 96. Roche(Ventana Medical Systems) Recent Development
Table 97. Signal Rx Corporation Information
Table 98. Signal Rx Description and Business Overview
Table 99. Signal Rx Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Signal Rx Product
Table 101. Signal Rx Recent Development
Table 102. SpeBio Corporation Information
Table 103. SpeBio Description and Business Overview
Table 104. SpeBio Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. SpeBio Product
Table 106. SpeBio Recent Development
Table 107. Quimatryx Corporation Information
Table 108. Quimatryx Description and Business Overview
Table 109. Quimatryx Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Quimatryx Product
Table 111. Quimatryx Recent Development
Table 112. TetraLogic Pharmaceuticals Corporation Information
Table 113. TetraLogic Pharmaceuticals Description and Business Overview
Table 114. TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. TetraLogic Pharmaceuticals Product
Table 116. TetraLogic Pharmaceuticals Recent Development
Table 117. Onyx Corporation Information
Table 118. Onyx Description and Business Overview
Table 119. Onyx Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Onyx Product
Table 121. Onyx Recent Development
Table 122. Mirati Therapeutics Corporation Information
Table 123. Mirati Therapeutics Description and Business Overview
Table 124. Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Mirati Therapeutics Product
Table 126. Mirati Therapeutics Recent Development
Table 127. Karus Therapeutics Corporation Information
Table 128. Karus Therapeutics Description and Business Overview
Table 129. Karus Therapeutics Histone Deacetylase(HDAC) Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Karus Therapeutics Product
Table 131. Karus Therapeutics Recent Development
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Histone Deacetylase(HDAC) Inhibitors Players
Table 136. Histone Deacetylase(HDAC) Inhibitors Customers List
Table 137. Histone Deacetylase(HDAC) Inhibitors Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Histone Deacetylase(HDAC) Inhibitors Product Picture
Figure 2. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Hydroxamic Acids Product Picture
Figure 4. Cyclic Tetrapeptides Product Picture
Figure 5. Benzamides Product Picture
Figure 6. Electrophilic Ketones Product Picture
Figure 7. Aliphatic Acid Product Picture
Figure 8. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 9. Psychiatry and Neurology
Figure 10. Cancer Treatment
Figure 11. HIV
Figure 12. Others
Figure 13. Histone Deacetylase(HDAC) Inhibitors Report Years Considered
Figure 14. Global Histone Deacetylase(HDAC) Inhibitors Market Size 2015-2026 (US$ Million)
Figure 15. Global Histone Deacetylase(HDAC) Inhibitors Sales 2015-2026 (K Pcs)
Figure 16. Global Histone Deacetylase(HDAC) Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Region (2015-2020)
Figure 18. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Region in 2019
Figure 19. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Region (2015-2020)
Figure 20. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Region in 2019
Figure 21. Global Histone Deacetylase(HDAC) Inhibitors Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Histone Deacetylase(HDAC) Inhibitors Revenue in 2019
Figure 23. Histone Deacetylase(HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Type (2015-2020)
Figure 25. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Type in 2019
Figure 26. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Type (2015-2020)
Figure 27. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Type in 2019
Figure 28. Global Histone Deacetylase(HDAC) Inhibitors Market Share by Price Range (2015-2020)
Figure 29. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Application (2015-2020)
Figure 30. Global Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Application in 2019
Figure 31. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Application (2015-2020)
Figure 32. Global Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Application in 2019
Figure 33. China Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. China Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. China Histone Deacetylase(HDAC) Inhibitors Market Share in Global Market 2015-2026
Figure 36. China 5 and 10 Largest Histone Deacetylase(HDAC) Inhibitors Players Market Share by Revenue in Histone Deacetylase(HDAC) Inhibitors in 2019
Figure 37. China Histone Deacetylase(HDAC) Inhibitors Revenue Share by Type (2015-2020)
Figure 38. China Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 39. China Histone Deacetylase(HDAC) Inhibitors Revenue Share by Application (2015-2020)
Figure 40. China Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Country in 2019
Figure 44. North America Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Country in 2019
Figure 45. U.S. Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Country in 2019
Figure 52. Europe Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Country in 2019
Figure 53. Germany Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Sales Market Share by Region in 2019
Figure 66. Asia Pacific Histone Deacetylase(HDAC) Inhibitors Revenue Market Share by Region in 2019
Figure 67. China Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Histone Deacetylase(HDAC) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Histone Deacetylase(HDAC) Inhibitors Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Histone Deacetylase(HDAC) Inhibitors Reven

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs